1Gadzicki D,von Neuhoff N,Steinemann D et al.BCRABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib[J].Cancer Genet Cytogenet,2005,159(2):164-167
2Willis S,Lange T,Demehri S,et al.High sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients:correlation with clonal cytogenetic evolution but not response to therapy[J].Blood,2005,24
3Yamamoto M,Kakihana K,Kurosu T.Clonal evolution with inv(11) (p15q22) and NUP98/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia[J].Cancer Genet Cytogenet,2005,157:104-8
4Marktel S,Marin D,Foot N,et al.Chronic myeloid leukemia in chronic phase responding to imatinib:the occurrence of additional cytogenetic abnormalities predicts disease progression[J].Haematologica,2003,88:260-267
5Schoch C,Haferlach T,Kern W,et al.Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate[J].Leukemia,2003,17:461-463
